We are running a survey on post-psychedelic trip difficulties and what helped to cope with which specific difficulty, so if you have had extended challenging psychedelic experiences please do this 15min survey... all respondents get a copy of Jules' book Breaking Open
No. That’s not how this works. Any serious company seeking fda approval is going to look at how MAPS conducted itself, and then do better, or suffer the same fate
This is one of the 2 big lessons for me: listen and even amplify criticism - medical scientists can never forget that it is all about the patients and the patients are often vulnerable. Engaging with criticism is the only honest and ethical way to do psychiatric science.
Really delighted to have joined the teaching faculty of Clerkenwell Health for their "Psychedelic Practitioner Foundation Programme".
Follow this link to find out more (via the FAQ) and to sign up for the Foundation Programme.
https://t.co/kR8kNLBHkl
Desperately sad news that Russell Newcombe has died.
Educator, campaigner, harm reduction trailblazer, psychonaut, and an endlessly fascinating, generous and lovely human - He will be terribly missed. RIP 😔
1/
With @neurodelia and @Imperial_PRG we just launched a 🆒🆕 study to understand the practices used in underground #psychedelic therapy and how they differ from what we do in clinical trials.
Please RT, forward to relevant ppl in your network🙏
More info: https://t.co/KjGCmkquvm
Please RT: We’re running a study looking at people’s experience of ketamine addiction treatment - heavy ketamine users current and past welcome https://t.co/HxkO2szcft
I had the pleasure of helping run his campaign for London mayor in 2016 with @steve4good & @paulbirch99. Great piece on Lee by @damiengayle at the time: https://t.co/wIoIoXZ5Ar
One of those amazing people full of the most incredible stories that seems to always have been at the right place at the right time in history. He'll be missed by many!
Recruitment announcement:-
Come & join me on The Loop Board of Trustees!
The Loop CIO is expanding its Board ahead of an exciting new phase of expansion of #harmreduction services coming very soon.
If you know a suitable competent & committed accountant please RT to them. 🙏🏻
Nice to see our @clerkenwell_uk rapid response to the recent reanalysis of the STAR*D trial results published in the @BMJ_Open - suggesting that new treatments for depression have a place sooner than as a last resort in treatment resistant populations https://t.co/5wPw1Fp4SS
I’m excited about this - a frank, thoughtful, and participatory discussion of interdisciplinarity in psychedelic research with @NeseLSD and Emily Bloesch!
Check out these highlights from our discussion led by Clerkenwell Health at PSYCH Symposium: London 2023. Our CEO, Nick Kadysh shares his thoughts on the importance of collaboration in this sector.
Read more: https://t.co/6DgUBJcA73
#mdma#mdxx#psychedelics#clinicaltrails
We are recruiting for a study on 'the many faces of psychedelic transformations': positive, negative and mixed significant changes. Please share to contribute to our understanding of the different outcomes that follow psychedelic experiences
https://t.co/kpdYU5gyhj